These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Search for epitope-specific antibody responses to the human immunodeficiency virus (HIV-1) envelope glycoproteins signifying resistance to disease development. Neurath AR, Strick N, Taylor P, Rubinstein P, Stevens CE. AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1183-92. PubMed ID: 1701315 [Abstract] [Full Text] [Related]
3. Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1). Neurath AR, Strick N. Mol Immunol; 1990 Jun; 27(6):539-49. PubMed ID: 1696353 [Abstract] [Full Text] [Related]
5. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera. Blomberg J, Lawoko A, Pipkorn R, Moyo S, Malmvall BE, Shao J, Dash R, Tswana S. AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754 [Abstract] [Full Text] [Related]
7. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells. Stamatatos L, Zolla-Pazner S, Gorny MK, Cheng-Mayer C. Virology; 1997 Mar 17; 229(2):360-9. PubMed ID: 9126249 [Abstract] [Full Text] [Related]
11. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein. Richardson TM, Stryjewski BL, Broder CC, Hoxie JA, Mascola JR, Earl PL, Doms RW. J Virol; 1996 Feb 17; 70(2):753-62. PubMed ID: 8551612 [Abstract] [Full Text] [Related]
12. Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides. Haynes BF, Torres JV, Langlois AJ, Bolognesi DP, Gardner MB, Palker TJ, Scearce RM, Jones DM, Moody MA, McDanal C. J Immunol; 1993 Aug 01; 151(3):1646-53. PubMed ID: 8335949 [Abstract] [Full Text] [Related]
13. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein. Haynes BF, Arthur LO, Frost P, Matthews TJ, Langlois AJ, Palker TJ, Hart MK, Scearce RM, Jones DM, McDanal C. J Exp Med; 1993 Mar 01; 177(3):717-27. PubMed ID: 7679708 [Abstract] [Full Text] [Related]
14. Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Broliden PA, von Gegerfelt A, Clapham P, Rosen J, Fenyö EM, Wahren B, Broliden K. Proc Natl Acad Sci U S A; 1992 Jan 15; 89(2):461-5. PubMed ID: 1370580 [Abstract] [Full Text] [Related]
15. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides. Filice G, Soldini L, Orsolini P, Razzini E, Gulminetti R, Campisi D, Chiapparoli L, Cattaneo E, Achilli G. Microbiologica; 1991 Jul 15; 14(3):185-94. PubMed ID: 1717811 [Abstract] [Full Text] [Related]
16. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries. Boots LJ, McKenna PM, Arnold BA, Keller PM, Gorny MK, Zolla-Pazner S, Robinson JE, Conley AJ. AIDS Res Hum Retroviruses; 1997 Dec 10; 13(18):1549-59. PubMed ID: 9430247 [Abstract] [Full Text] [Related]
17. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66. Manca F, Fenoglio D, Valle MT, Li Pira G, Kunkl A, Ferraris A, Saverino D, Lancia F, Mortara L, Lozzi L. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul 01; 9(3):227-37. PubMed ID: 7540488 [Abstract] [Full Text] [Related]